Cited by 28Ovarian function and disordersEndometriosis Research and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome

Altinok, Magda Lambaa, Ravn, Pernille, Andersen, Marianne, Glintborg, Dorte·2018·Gynecological Endocrinology

Abstract

Health-related quality of life (HRQoL) is impaired in polycystic ovary syndrome (PCOS), but the effect of treatment with metformin (M) and/or oral contraceptives (OCP) is undetermined. To assess changes in HRQoL during 12-month randomized treatment with M, OCP or M + OCP in PCOS. Ninety women with PCOS were randomized to treatment with M, OCP or M + OCP. HRQoL was evaluated by a PCOS-specific visual analog scale (PCOS-VAS) regarding 1: Facial hair, 2: Body hair, 3: Acne, 4: Irregular menses, 5: Weight and 6: PCOS in general, and Short Form 36 (SF-36). PCOS-VAS1(facial hair) improved during treatment with OCP (n = 23) compared to M (n = 19), and during M + OCP (n = 23) compared to M treatment, whereas changes in PCOS-VAS2-6 and SF-36 scores were comparable between the three medical intervention groups. Pooled data (n = 65) showed improved PCOS-VAS scores during treatment (all p < .05), but changes in PCOS-VAS were unassociated with changes in BMI or FG-scores despite significant weight-loss during treatment with M (-3.0 kg (-10.3; 0.6)) and M + OCP (-1.9 kg (-4.9; 0.1)) and decreased FG-score during M + OCP treatment (median (quartiles)). PCOS-VAS scores improved significantly and to the same extent during treatment with M, OCP or M + OCP.

Integrity signals

Registry

Crossref · 10.1080/09513590.2018.1460343

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Altinok, M. L., Ravn, P., Andersen, M., & Glintborg, D.
Affiliations
Odense University Hospital (DK)
Corresponding author
Altinok, Magda Lambaa
Venue
Gynecological Endocrinology
Published
2018-04-16
Volume
34
Issue
10
Pages
859-863
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W2802047677
Cited by
28
References
31
Citations by year
2025: 4 · 2024: 2 · 2023: 9 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 1
FWCI
2.67
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Funders
  • the Jacob Madsen’s and Olga Madsen’s Foundation
  • the Institute of Clinical research
  • Odense University Hospital
  • Kolding Hospital
  • A.P. Møller’s Foundation
  • Bernard and Marie Klein’s Foundation
  • the Novo Nordisk Foundation
  • the Danish Medical Association
  • Sandoz
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
polycystic ovary syndrome, metformin, oral contraceptives, health-related quality of life, facial hair, body hair, acne, menstrual irregularity, weight loss, insulin resistance, SF-36
MeSH terms
Adolescent, Adult, Contraceptives, Oral, Hormonal, Female, Humans, Hypoglycemic Agents, Metformin, Polycystic Ovary Syndrome, Quality of Life, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review